Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reticuloendothelial Cell Phagocytosis (RES Phagocytosis)
- Target
- RES Phagocytosis
- Molecular classification
- Cellular Process, Immune Process, Phagocytosis, Innate Immunity
01
Overview
Reticuloendothelial cell phagocytosis is the process by which specialized cells of the reticuloendothelial system (RES), primarily macrophages and monocytes, engulf and remove foreign particles, pathogens, cellular debris, and other substances from the blood and tissues. This function is a critical component of innate immunity and tissue homeostasis. Altered RES function has implications for infectious disease susceptibility, immune complex diseases and cancer.
- Other names
- Mononuclear Phagocyte System PhagocytosisRES mediated clearanceMacrophage-mediated phagocytosisPhagocytosis by Kupffer cells/splenic macrophages
02
Mechanism of action
Phagocytic cells recognize targets via pattern recognition receptors or opsonins. Upon recognition, cells engulf particles through cytoskeletal rearrangement forming a phagosome. The internalized material is degraded within lysosomes.
03
Biological functions
Pathogen clearanceRemoval of apoptotic cellsClearance of cellular debrisImmune complex clearanceAntigen presentationTissue homeostasisRegulation of immune responses
04
Disease associations
Infectious diseaseImmune complex diseasesCancerSepsisTraumaShockImmunodeficiencyInflammation
05
Safety considerations
Impaired phagocytosis (increased susceptibility to infection)Excessive phagocytosis (inflammation, tissue damage)Dysregulation of immune responsesOff-target effects of drugs affecting RES function
06
Interacting drugs
Nanoparticles (drug delivery systems)
3 more in the full profile.
07
Biomarkers
Clearance rate of labeled colloids or proteinsMacrophage activation markers (e.g., CD68, CD163)Cytokine levels (e.g., TNF-alpha, IL-10)Monocyte countsPhagocytic capacity assays (in vitro)
Beyond the preview
Go deeper on Reticuloendothelial Cell Phagocytosis (RES Phagocytosis).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reticuloendothelial Cell Phagocytosis (RES Phagocytosis).